Business Name: |
Mendenhall James V MD |
Contact Person: |
James Mendenhall |
Address: |
1702 South Mattis Avenue, Champaign, Illinois 61821 |
Phone Number: |
(217) 326-2030 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Ronald E Kimball M D A Professional Corporation - Champaign, IL 61821 Moran Michael C MD - Champaign, IL 61821 Jung Hyunchul MD - Champaign, IL 61821 Panos Reed G MD - Champaign, IL 61821 Hawley Charles K MD - Champaign, IL 61821 Kawakita Erick M MD - Champaign, IL 61821 Almasri Hussam MD - Champaign, IL 61821 Kurley James M MD - Champaign, IL 61821 Zeman David R MD - Champaign, IL 61821 Solomon Tesfaye MD - Champaign, IL 61821 Dr Ines O Baquero Md - Champaign, IL 61821 Wilson Kathryn A MD - Champaign, IL 61821 Convenient Care At County Mkt - Champaign, IL 61821 Kresca James R MD - Champaign, IL 61821 Risken Jared MD - Champaign, IL 61821 Wright Rebecca MD - Champaign, IL 61821 Tashakori Mahtab MD - Champaign, IL 61821 Johnson Jr Clifford B MD - Champaign, IL 61821 Duron Manuel MD - Champaign, IL 61821 A Dubrick Md Jd - Champaign, IL 61821 |
The company Mendenhall James V MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Mendenhall James V MD, and the business now earns $500.000 to $999.999 per annum.
Mendenhall James V MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Mendenhall James V MD, please call James Mendenhall with the phone number (217) 326-2030 or visit its single location at 1702 South Mattis Avenue in Champaign, Illinois 61821.
The location of the single location can also be found using the coordinates 40.09691,-88.27636.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.